Since the UK’s decision to leave the European Union last June, Nicola Sturgeon and the SNP have been convinced that Scotland’s vote to remain in the bloc provides perfect grounds to re-run the previously failed independence referendum.
Nine months after the Brexit referendum, Prime Minister Theresa May has notified European Council President Donald Tusk of the UK’s intention to leave the EU. Her letter starts the clock ticking: both sides have two years to agree a divorce settlement, and a framework for a future relationship.
The UK’s notification of Article 50 kicks off what may be a contentious withdrawal process. It is likely to take place in three stages.
There is only one certainty now that Theresa May has finally triggered Article 50 putting the rest of Europe on two year’s notice that the UK will be pulling out of its Union after 44 years.
The key concern for the international biopharma industry as the UK prepares to leave the European Union is regulation.
For most of its post-war history, the UK’s financial services industry was a distinctly parochial institution, far removed from the commanding heights of the UK economy, and far outstripped by international competitors.